A case with recovery from high degree atrioventricular-block with steroid therapy in cardiac sarcoidosis with AH block: a possible new sign of responder?. Issue 2 (February 2021)

• Record Type: Journal Article
• Authors: Ishida, Miwa; Niwano, Shinichi; Fujiyoshi, Kazuhiro; Ishida, Kohki; Ako, Junya; Inomata, Takayuki
• Is Part Of: Journal of cardiology cases. Volume 23:Issue 2(2021)
• Page Start: 90
• Page End: 93
• Publication Date: 2021-02
• Subjects: cardiac sarcoidosis -- atrioventricular block -- electrophysiologic study -- 18F-FDG PET; Cardiology -- Periodicals; Cardiovascular Diseases -- Case Reports; Cardiovascular Diseases -- Periodicals; Cardiology -- Case Reports; Cardiology -- Periodicals; Cardiology; Electronic journals; Periodicals; 616.12
• DOI: 10.1016/j.jccase.2020.10.005
• Languages: English
• ISSNs: 1878-5409

Abstract

Abstract: Background: Although some reports have documented cases who exhibited recovery from atrioventricular block (AVB) by steroid therapy in cases with cardiac sarcoidosis (CS), they could not determine predictors for such good response to steroid therapy. In this case, a 54-year-old female was referred to our hospital due to intermittent 2:1 AVB. Echocardiography revealed normal ventricular function. 18 F-fluorodeoxyglucose positron emission tomography ( 18 F-FDG PET) exhibited enhanced uptake in basal anterior-septal area of the left ventricle. The electrophysiologic study exhibited marked AH prolongation (324 ms) but no HV prolongation. Sarcoidosis was diagnosed basing on non-caseating granulomas detected in skin biopsy. Because the 2:1 AVB was temporal, oral prednisolone (PSL) was started without planning implantation of permanent pacemaker. In 10 days from start of PSL, PR interval was gradually normalized from 0.34 to 0.14 sec and temporal 2:1 AVB disappeared. 18 F-FDG PET also exhibited disappearance of enhanced uptake. During the following 2 years, the patient continued to exhibit normal PR interval. This case exhibited AH prolongation in EPS, although the degree of AVB was serious. Additionally, 18 F-FDG PET exhibited enhanced uptake in the area around AV-node. AH block and FDG enhancement around AV-node area might be novel predictors for good response to PSL in cases with CS. <Learning objective: Although early phase steroid therapy should be good for recovery of atrioventricular block in cardiac sarcoidosis (CS) cases, there is no useful predictor for the effect. Our case, a good responder to steroid therapy, exhibited fluorodeoxyglucose enhancement around AV node area and AH prolongation in electrophysiologic study. These findings might be good predictors for good response to steroid therapy in CS cases.>